Search Results - "Buntinx, Linde"

First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan.

Authors: Marynissen, Heleen Buntinx, Linde Bamps, Dorien et al.

Source: CTS: Clinical & Translational Science. Aug2022, Vol. 15 Issue 8, p1968-1977. 10p.

Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans.

Authors: Buntinx, Linde Chang, Lin Amin, Aasim et al.

Source: British Journal of Clinical Pharmacology. Mar2017, Vol. 83 Issue 3, p603-611. 9p.

Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model.

Authors: Buntinx, Linde Vermeersch, Steve Hoon, Jan

Source: British Journal of Clinical Pharmacology. Nov2015, Vol. 80 Issue 5, p992-1000. 9p. 2 Diagrams, 1 Chart, 2 Graphs.

The influence of migraine and female hormones on capsaicin-induced dermal blood flow.

Authors: Ibrahimi, Khatera Vermeersch, Steve Frederiks, Pascal et al.

Source: Cephalalgia. Oct2017, Vol. 37 Issue 12, p1164-1172. 9p.

Laser speckle contrast imaging, the future DBF imaging technique for TRP target engagement biomarker assays.

Authors: Bamps, Dorien Macours, Laura Buntinx, Linde et al.

Source: Microvascular Research. May2020, Vol. 129, pN.PAG-N.PAG. 1p.